Lipoatrophy, lipodystrophy, and insulin resistance

Ann Intern Med. 2000 Aug 15;133(4):304-6. doi: 10.7326/0003-4819-133-4-200008150-00017.
No abstract available

Publication types

  • Editorial
  • Research Support, U.S. Gov't, P.H.S.
  • Comment

MeSH terms

  • Body Composition / drug effects
  • Chromans / therapeutic use*
  • Diabetes Mellitus, Lipoatrophic / drug therapy*
  • Diabetes Mellitus, Lipoatrophic / physiopathology*
  • Humans
  • Hypoglycemic Agents / therapeutic use*
  • Insulin Resistance*
  • Lipodystrophy / drug therapy*
  • Lipodystrophy / physiopathology*
  • Syndrome
  • Thiazoles / therapeutic use*
  • Thiazolidinediones*
  • Troglitazone

Substances

  • Chromans
  • Hypoglycemic Agents
  • Thiazoles
  • Thiazolidinediones
  • Troglitazone